Page 80 - Clinical Small Animal Internal Medicine

48 Section 2 Endocrine Disease

Brearly MJ, Polton GA, Littler RM, et al. Coarse Meij BP, Auriemma E, Grinwis G, et al. Successful
VetBooks.ir fractionated radiation therapy for pituitary tumors in treatment of acromegaly in a diabetic cat with
transsphenoidal hypophysectomy. J Feline Med Surg
cats: a restrospective study of 12 cases. Vet Comp Oncol
2006; 4: 209–17.
2010; 12: 406–10.
Dunning MD, Lowrie CS, Bexfield NH, et al. Exogenous Meij BP, Voorhout G, van den Ingh TS, et al.
insulin treatment after hypofractionated radiotherapy in Transsphenoidal hypophysectomy for treatment of
cats with diabetes mellitus and acromegaly. J Vet Intern pituitary‐dependant hyperadrenocorticism in seven
Med 2009; 23: 243–9. cats. Vet Surg 2001; 30: 72–86.
Elliott DA, Feldman EC, Koblik PD, et al. Prevalence of Niessen SJM, Khalid M, Petrie G, Church DB. Validation
pituitary tumors among diabetic cats with insulin and application of an ovine radioimmunoassay for the
resistance. J Am Vet Med Assoc 2000; 216: 1765–8. diagnosis of feline acromegaly. Vet Rec 2007; 160: 902–7.
Feldman EC, Nelson RW. Disorders of growth hormone. Peterson ME, Taylor RS, Greco DS, et al. Acromegaly in 14
In: Canine and Feline Endocrinology and Reproduction, cats. J Vet Intern Med 1990; 4: 192–201.
3rd edn. Philadelphia, PA: WB Saunders, 2004, Posch B, Dobson J, Herrtage M. Magnetic resonance
pp. 69–84. imaging finding in 15 acromegalic cats. Vet Radiol
Feldman EC, Nelson RW. Acromegaly and Ultrasound 2011; 4: 422–7.
hyperadrenocorticism in cats: a clinical perspective. Scudder CJ, Niessen SJ, Catchpole B, et al. Feline
J Feline Med Surg 2000; 2: 153–8. hypersomatotropism and acromegaly tumorigenesis: a
Goldman L, Schafer AI. Growth hormone excess: potential role for the AIP gene. Domest Anim Endocrinol
acromegaly and gigantism. In: Goldman‐Cecil Medicine, 2017; 59: 134–9.
24th edn. Philadelphia, PA: Saunders Elsevier, 2012, Singerland LI, Voorhout G, Rijnberk A, et al. Growth
pp. 1437–8. hormone excess and the effect of octreotide in cats with
Gostelow R, Scudder C, Keyte S, et al. Pasireotide long‐ diabetes mellitus. Domest Anim Endocrinol 2008; 35:
acting release treatment for diabetic cats with 352–61.
underlying hypersomatotropism. J Vet Intern Med 2017; Starkey SR, Tan K, Church DB. Investigation of serum
31(2): 355–64. IGF‐I levels amongst diabetic and non‐diabetic cats.
Kenny P, Scudder C, Keyte S, et al. Treatment of feline J Feline Med Surg 2004; 6: 149–55.
hypersomatotropism. Efficacy, morbidity and Timian J, Lunn KF. Evaluation of a long‐acting
mortality of hypophysectomy. J Vet Intern Med 2015; somatostatin receptor ligand for the treatment of feline
29: 1271. acromegaly. J Vet Intern Med 2012; 26: 757.
Kittleson MD, Pion PD, DeLellis DA, et al. Increased Wormhoudt TL, Boss MK, Lunn K, et al. Stereotactic
serum growth hormone concentration in feline radiation therapy for the treatment of functional
hypertrophic cardiomyopathy. J Vet Intern Med 1992; pituitary adenomas associated with feline acromegaly.
6: 320–4. J Vet Intern Med 2018; 32: 1383–91.